Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Meningitis × Topotecan × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 44 Brain Neoplasms 18 Glioma 11 Central Nervous System Neoplasms 11 Medulloblastoma 8 Neoplasms 6 Gliosarcoma 6 Glioblastoma 6 Ganglioneuroblastoma 6 Astrocytoma 6 Sarcoma, Ewing 5 Sarcoma 5 Rhabdomyosarcoma 5 Rhabdoid Tumor 5 Recurrence 5 Meningeal Carcinomatosis 5 Wilms Tumor 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Oligodendroglioma 3 Lymphoma 3 Familial ependymoma 3 Dendritic Cell Sarcoma, Interdigitating 3 Burkitt Lymphoma 3 Testicular Neoplasms 2 Retinoblastoma 2 Osteosarcoma 2 Optic Nerve Glioma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neoplasm Metastasis 2 Lymphoma, Follicular 2

Interventions

ziprasidone 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Topotecan 1 Tobramycin 1 Spironolactone 1 Sevelamer 1 Rocuronium 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Nafcillin 1 Music Therapy 1 Molindone 1 Methylprednisolone 1 Lurasidone Hydrochloride 1 Labetalol 1 Haloperidol 1 Gemcitabine 1 Fosfomycin 1 Dialectical Behavior Therapy 1 Clozapine 1 Ciprofloxacin 1 Cidofovir 1 Cholecalciferol 1 Cefepime 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00674674 2012-05-15

PBTC-019

Baylor College of Medicine

Phase 1 Completed

Meningitis, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡